HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cell kill kinetics of an antineoplastic nucleoside, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytosine.

Abstract
The cytotoxic properties of 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytosine (DMDC) were compared with those of 1-beta-D-arabinofuranosylcytosine (ara-C), using SK-MEL-28(P-36) human melanoma cells. DMDC and ara-C were most cytotoxic to cells in the S phase of the cell cycle. Cell cycle progression in S phase was blocked by both compounds. Treatment with DMDC (1 microgram/mL) or ara-C (1 and 30 micrograms/mL) did not increase cytotoxicity against asynchronous cells when the exposure time was prolonged from 1 to 6 hr, but did increase cytotoxicity thereafter. These findings suggest that cells in S phase are rapidly killed by the treatment but are temporarily prevented or delayed entry into the drug-sensitive S phase. On the other hand, DMDC treatment at a higher concentration (30 micrograms/mL) increased cytotoxicity in a time-dependent manner. Intracellular DMDC 5'-triphosphate (DMDCTP) increased in proportion to exogenous DMDC concentration, which was not saturated by treatment with a maximum concentration of the compound at 80 micrograms/mL. In contrast, intracellular ara-C 5'-triphosphate reached peak level when the cells were treated with ara-C at 8 micrograms/mL. The cytotoxicity of DMDC treatment for 4 hr increased relative to the intracellular DMDCTP accumulated during the period. These findings suggest that in cells treated with DMDC at a high concentration, an effective DMDCTP level is maintained for an extended period after washing out the compound from the medium. Consequently, the cells would be killed in the same way as in the case of extended exposures over 6 hr to DMDC at low concentration or to ara-C, in addition to acute S-phase-specific cytotoxicity.
AuthorsT Ono, A Fujii, K Yamagami, M Hosoya, T Okumoto, S Sakata, A Matsuda, T Sasaki
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 52 Issue 8 Pg. 1279-85 (Oct 25 1996) ISSN: 0006-2952 [Print] England
PMID8937436 (Publication Type: Journal Article)
Chemical References
  • 1-(2-deoxy-2-methylene-erthyro-pentofuranosyl)cytosine 5'-triphosphate
  • Antineoplastic Agents
  • Deoxycytosine Nucleotides
  • Cytarabine
  • Deoxycytidine
  • 2'-deoxy-2'-methylenecytidine
Topics
  • Antineoplastic Agents (metabolism, pharmacology)
  • Cell Cycle (drug effects)
  • Cell Death (drug effects)
  • Cytarabine (pharmacology)
  • Deoxycytidine (analogs & derivatives, metabolism, pharmacology)
  • Deoxycytosine Nucleotides (metabolism)
  • Humans
  • Kinetics
  • Phosphorylation
  • S Phase (drug effects)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: